Harvesting MSCs and EpSCs from Cord Lining with CellOptima™
Patented Technology with 44 Patent Protection granted in 40 Countries
Available exclusively at Cordlife in India, CellOptima™ is a proprietary technique and verification process where a portion of the umbilical cord lining is processed through multiple passaging to validate the presence of various cell type/s. The technique also validates the capability of the Stem Cells derived from umbilical cord lining to be able to expand in future.
Quick Tip What makes CellOptima™ special? CellOptima™ is an original invention from Singapore. Patent protection of CellOptima™ has been granted by many countries because the technology is novel, first-of-its-kind and useful. All patents granted for CellOptima™ prevents other companies from harvesting stem cells from cord lining. |
List of Clinical Trials with Stem Cells harvested with CellOptima™
Focus | Partner Universities or Research Institutions |
Heart restoration and repair |
|
Wound management and burns |
|
Cornea regeneration |
|
Liver regeneration |
National University of Singapore |
Skin & hair rejuvenation |
|
Insulin-producing cells |
|
Neuronal differentiation for hearing impairment | Stanford University, United States |
Bone differentiation, repair and regeneration |
|
Hemophilia A | National Cancer Centre, Singapore |
Human feeder layer for stem cell culture | Duke University, United States and National University of Singapore (co-collaboration) |
Subscribe to our newsletter